Training Health Promotion Women Community Leaders
Launched by HADASSAH MEDICAL ORGANIZATION · Aug 2, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on training women to become community leaders in health promotion. The goal is to help participants learn how to plan, implement, and evaluate programs that encourage healthier lifestyles and reduce sedentary behavior, which means sitting too much. By participating, women will develop skills that not only benefit themselves but also empower them to support their communities in making healthier choices.
To be eligible for this trial, women aged between 36 and 75 who have already taken part in a diabetes prevention program (DPP) can apply. Participants should also have an interest in creating health promotion programs. If you join, you can expect to engage in training that enhances both your personal skills and your ability to work with others in your community to promote better health. The study is currently looking for participants, so it's a great opportunity to make a positive impact!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • had to previously take part in the previously implemented diabetes prevention program (DPP)
- • had to have interest and ability in developing programs
- Exclusion Criteria:
- • -
About Hadassah Medical Organization
Hadassah Medical Organization (HMO) is a leading healthcare institution based in Jerusalem, Israel, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, HMO leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research across various therapeutic areas. The organization is dedicated to fostering collaboration between clinical researchers, healthcare professionals, and academic institutions, ensuring the highest standards of ethical practice and scientific rigor. HMO's mission is to translate groundbreaking research into effective treatments, ultimately enhancing health outcomes for diverse populations both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Donna Zwas, MD MPH
Principal Investigator
Hadassah Medical Organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials